Abstract ID Presenting Author Organisation Abstract Title
8 Venkateswaran  V S Meenakshi Mission Hospital & Research Centre, Madurai Refractory Hypoglycemia in the Post-Transplant Period: A Case of Drug-Induced Hyperinsulinism in Omenn Syndrome”
9 Arjun Chawla BLK Max Super Speciality Hospital, Delhi Evaluation of a nurse led supportive care protocol in hematopoietic stem cell transplant recipients: a three month pilot study from 1 October 2025 to 1 January 2026
10 Pallavi BLK MAX Super Speciality Hospital, New Delhi Role of a transplant coordinator in Acquiring Matched Unrelated Donor (MUD) Stem Cell Product for Hematopoietic Stem Cell Transplantation
11 Venkateswaran V S Meenakshi Mission Hospital & Research Centre, MADURAI Learning from Rarity: Rare Diagnoses, Rare Presentations, and Rare Complications in Inborn Errors of Immunity Undergoing HSCT.”
12 Anitha V Meenakshi Mission Hospital & Research Centre, Madurai Vedolizumab in Pediatric Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease: A Single-Center Experience
13 Shweta Pathak Netaji Subhash Chandra Bose Medical College, Jabalpur Decentralizing Pediatric Hematopoietic Stem Cell Transplantation in India: Establishment and Early Outcomes from a Government Medical College
14 Venkateswaran V S Meenakshi Mission Hospital and Research Centre, Madurai HSCT is not an one man show- The role of multidisciplinary team in improving the outcome of children undergoing HSCT
15 Venkateswaran V S Meenakshi Mission Hospital and Research Centre, Madurai Immune Architect: Rebuilding Life through Pediatric Stem Cell Transplantation- are we there yet?
16 Viral Jain Dr B L Kapur Memorial Hospital, New Delhi Thiotepa and treosulfan based myeloablative conditioning in t-cell replete haploidentical hematopoietic stem cell transplant among patients with hematological disorders
17 Shweta Pathak Netaji Subhash Chandra Bose Medical College, Jabalpur Steroid-Refractory Pediatric Gut GVHD After HSCT for Sickle Cell Disease: Successful Salvage with MSC Therapy and Sequential Targeted Immunosuppression in a Resource-Limited Setting
19 Divyam Deepak Waghate Jaslok Hospital & Reasearch Centre, Mumbai Impact of infection preventive and control sanitization practices on infection prevention in the bone marrow transplant unit.
22 K. Jothi DKMS Foundation, Bengaluru From Diagnosis to Cure: Strengthening Access through the DKMS Access to Transplantation (ATT) Program
24 Sanjana Dontula DKMS Foundation, Bangalore Beyond HLA Typing: Barriers to Transplantation and Conversion Outcomes in DKMS Thalassemia Program
25 Venkateswaran V S Meenakshi Mission Hospital & Research Centre, Madurai Letermovir prophylaxis: hype or hope? Real-world data on the impact of letermovir in children undergoing hematopoietic stem cell transplantation at a tertiary referral centre in southern India
26 Akanksha Garg Zydus Cancer Hospital, Ahmedabad Outcomes of Allogenic Stem Cell Transplantation in Paediatric Chronic Myeloid Leukemia
27 Megha ACTREC, Tata Memorial Centre, Navi Mumbai Outcomes of Salvage Second Autologous SCT in Relapsed Multiple Myeloma from a large Tertiary Cancer Centre in India.
30 Jimy Patel Dr. B L Kapur Memorial Hospital, New Delhi Efficacy of Letermovir  as CMV prophylaxis in haplo-HSCT – Early experience from a single center.
31 Himanshu Christian Medical College, Ludhiana, Ludhiana Flexible and Bayesian survival modelling for post-transplant survival prediction in thalassemia major.
33 Sohini Chakraborty Fortis Memorial Research Institute, Gurugram Outcome of Hematopoietic stem cell transplantation in pediatric acquired aplastic anaemia – a single center experience
34 Sohini Chakraborty Fortis Memorial Research Institute, Gurugram Matched unrelated donor hematopoietic stem cell transplantation in children with thalassemia – a single center experience
35 Santosh Kumar Medanta, Patna Experience of Hematopoietic Stem Cell Transplantation at a Tertiary Care Centre in Bihar
36 Tanista Badiya PGIMER, Chandigarh An open- labelled randomized controlled trial to assess the efficacy of prophylactic  administration of romiplostim for platelet recovery in patients post hematopoietic stem cell  transplantation
37 Pooja Chauhan PGIMER, Chandigarh Guarding the Gate: Letermovir Prophylaxis Post-Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Prevents Clinically Significant Cytomegalovirus (CMV) Disease — Real-World Outcomes from a Tertiary Care Centre in India
38 Tanista Badia PGIMER, Chandigarh An open- labelled randomized controlled trial to assess the efficacy of prophylactic administration of romiplostim for platelet recovery in patients post hematopoietic stem cell transplantation- An interim report
40 Arpita Gupta LTMMC & GH, Mumbai Parvovirus B19 Infection in Paediatric Patients with Transfusion-Dependent Thalassemia Following Allogeneic Hematopoietic Cell Transplantation: A Single-Centre Experience.
42 Sarbani Bagchi St. John’s Medical College Hospital, Bangalore Screening of related donors before allogenic hematopoietic stem cell transplant for inherited disorders: A study from a referral centre in South India
43 Siddappareddigari Kishore Kumar Cancer Institute (WIA), Chennai Retrospective Analysis of 12-Year Outcomes of Patients with Acute Lymphoblastic  Leukemia Treated with allogenic Hematopoietic Stem Cell Transplantation in Adult  and Pediatric Populations: A Single Center Experience
44 Venkateswaran V S Meenakshi Mission Hospital and Research Centre, Madurai Post transplant cyclophosphamide in infants undergoing haploidentical HSCT- Case series from a tertiary referral centre in southern India
46 Sachin Punatar ACTREC, Tata Memorial Centre, Navi Mumbai A Phase III, Randomized, Double-Blind, Placebo Controlled Study of curcumin to reduce mucositis in autologous transplant setting
47 Satyendra Batra Fortis Memorial Research Institute, Gurugram Inotuzumab Ozogamicin as a Bridge to Hematopoietic Stem Cell Transplantation in Pediatric Relapsed/Refractory B-ALL
48 Raj Gabani Apollo Hospitals, Gandhinagar, Gandhinagar Letermovir cytomegalovirus prophylaxis in allogenic hematopoietic cell transplantation: Real-world  evidence from high-endemic region
51 Vinit Sambhaji Teli TMC-ACTREC, KHARGHAR,NAVI MUMBAI Perceived stressors and coping strategies among post hematopoetic stem cell transplant patients in a tertiary care hospital
52 Rohan Jacob Verghese Advanced Centre for Treatment, Research and Educat, Navi Mumbai Incidence, risk factors and outcomes of avascular necrosis in allogeneic stem cell transplant recipients developing GvHD
53 Ankita Singh Amrita Institute of Medical Sciences, Faridabad Reduced-Toxicity Myeloablative TBI-based conditioning for ≥2-mismatch partially matched related donor HSCT with PTCy in high-risk hematological malignancies: single-centre real-world outcomes from India
54 Ankita Singh Amrita Institute of Medical Sciences, Faridabad Resource-adapted immunotherapy bridging to achieve MRD-negativity prior to allogeneic HSCT in high-risk ALL: A single-centre real-world experience
55 Ankita Singh Amrita Institute of Medical Sciences, Faridabad Feasibility and impact signals of an ANC-triggered prophylactic/pre-emptive granulocyte transfusion program in T-cell replete partially matched related donor HSCT for hematological malignancies, a single-centre experience
57 Dinesh Ravikumar Cancer Institute, WIA, Chennai Comparable Outcomes Across Donor Types in Allogeneic HSCT for Acute Myeloid Leukaemia: A 12-Year Single-Centre Real-World Study
58 Moiz Bashir Doctor Manipal Hospital Bangalore, Bangalore Comparison of Stem Cell Mobilization Strategies in Autologous Hematopoietic Stem Cell Transplantation: A Single-Center Study
59 Krithika Krishnakumar Apollo Cancer Centre, Chennai Controlled GVHD as a Therapeutic Goal: NK Cell–Driven Alloreactivity Enhances GVL and Survival in Pediatric HSCT- A Case series from a single centre in India
60 Krithika Krishnakumar Apollo Cancer Centre, Chennai Making HSCT safer for children with sickle cell disease
61 Krithika Krishnakumar Apollo Cancer Centre, Chennai Not Just Surviving but Thriving – PedsQL-Measured Quality of Life in Long-Term Survivors Following HSCT for IBMFS
63 Krithika Krishnakumar Apollo Cancer Centre, Chennai Letermovir Prophylaxis – real world data on Cytomegalovirus Reactivation in Paediatric Haematopoietic Stem Cell Transplantation Recipients: A Single-Centre experience
68 Aieswarya.S Narayana Health City, Banglore Real-world outcomes of CAR-T Cell Therapy in relapsed/refractory B-Cell malignancies: A single-centre experience
70 Vaibhav Chadha Fortis Memorial Research Institute , Gurgaon Encouraging outcomes with Fludarabine based conditioning in Haplo family  donor transplants in Hemoglobinopathies: Lessons learned in last few years.
72 Rohan Halder Rajiv Gandhi Cancer Institute & Research Centre, Delhi Varnimcabtagene Autoleucel in treatment of Relapsed/Refractory B-cell Lymphomas in Clinical Practice: A Single-Centre Real-World Experience from North India
74 Parminder Pal Singh Fortis Memorial Research Institute, Gurugram Outcomes of alternate donor haematopoietic stem cell transplantation in acute leukemia – experience from a tertiary care centre in Nrth India
76 Karthick Velavan Madras Medical College, Chennai Letermovir prophylaxis for cmv in paediatric alternative donor HSCT: Real-world evidence from an Indian tertiary centre
85 Perimbeti Hemalatha Sankalp India Foundation, Bangalore Preventing infections together: One year infection control trends in Sankalp India Foundation
87 Rohan Halder Rajiv Gandhi Cancer Institute & Research Centre, Delhi Hypomethylating Agents with Venetoclax as Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukaemia
89 Shanmitha Padmanaban Mazumdar shaw medical centre , NH health City , Bangalore The Art of Donor Lymphocyte infusion
90 Nishkala U Rao Deenanath Mangeshkar Hospital and Research Center, Pune Extracorporeal photopheresis in steroid-refractory graft-versus-host disease: a single-center experience
92 Rachna Shanbhag Mohite BJ Wadia Hospital, Mumbai Precision protection: Harnessing Memory T cells to treat Viral reactivation in haploidentical T deplete transplants without GvHD exacerbation
93 Bhanu Pratap Singh Chauhan ACTREC Tata Memorial Hospital, Navi Mumbai Standard Cytogenetic Risk Myeloma – Does it Matter in India if Transplanted in First Remission versus Later
94 Michael L J Pais St. John’s Medical College Hospital, Bangalore Early and serial amniotic membrane transplantation for vision salvage in severe ocular GVHD
96 Sunil Bhat Narayana Health City, Bangalore TCR alpha/beta Depletion in Haploidentical Transplantation for Pediatric Patients
97 Mir Mohmad Hussain Sher-i-Kashmir Institute of Medical Sciences, Srinagar Non-cryopreserved autologous stem cell transplantation in Lymphoma in a resource-limited setting: feasibility, engraftment kinetics, and early outcomes from Kashmir, India.
98 Arutla Sravani Rainbow Hospital, Hyderabad Single Centre Experience in Allogenic Hematopoietic stem cell transplantation in Inherited bone marrow failure syndromes.
99 Gaurav Lalit Lalwani Jaslok Hospital & Research Institute, Mumbai Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Mixed Phenotype Acute Leukemia: A Real-World Single-Center Experience
100 Swapnil Tripathi Rajiv Gandhi Cancer Institute and Research Centre , New Delhi Feasibility and Safety of Reduced-Dose Post-Transplant Cyclophosphamide Combined with Rabbit Anti-Thymocyte Globulin for Graft-Versus-Host Disease Prophylaxis in  Haploidentical donor stem cell transplant: A Single-Center Retrospective Case Series
101 Gokulakrishnan T Apollo Cancer Speciality Hospital, Chennai Moving Beyond TBI Early Outcomes of Total Marrow and Lymphoid Irradiation (TMLI) based conditioning in Adult Leukemias.
102 Gaurav Lalit Lalwani Jaslok Hospital & Research Institute, Mumbai Experience with Total Marrow and Lymphoid Irradiation (TMLI)–Based Conditioning in Acute Leukemia: A Single-Center Experience from India.
103 Naznin Parvin St. John’s Medical College Hospital, Bangalore Therapeutic Drug Monitoring in Antifungal Prophylaxis in Paediatric Allogeneic HSCT, A Retrospective Cohort Study
104 S. Lakshmi Chitra Rajiv Gandhi Government General Hospital, Chennai Hematopoietic Stem Cell Transplantation in Fanconi Anemia: Outcomes and Challenges from a Single-Center Experience
105 S. Lakshmi Chitra Rajiv Gandhi Government General Hospital, Chennai Curative Potential of Allogeneic Stem Cell Transplantation in Paroxysmal Nocturnal Hemoglobinuria: A Two-Case Experience
106 Chitralekha Thamizhvendan Cancer Institute (WIA), Chennai Optimizing Stem Cell Yield in Lymphoma: Real-World Outcomes of High-Dose Cytarabine–Etoposide Chemo-mobilisation
107 Rajul Jain Omega Hospitals, Hyderabad Disseminated mixed Aspergillus–Nocardia infection after haploidentical hematopoietic stem cell transplantation
109 Ajmeera A Azeez Narayana Health City, Bangalore Clinical impact of busulfan pharmacokinetic monitoring in pediatric allogeniec transplants
110 Aparna Pradeep PGIMER, Chandigarh Post Transplant Cyclophosphamide +Cyclosporin ( PTCY+ CSA)–versus Cyclosporin–Methotrexate( CSA+ MTX) as Graft versus Host Disease (GVHD)Prophylaxis in Matched Sibling Donor(MSD) Transplantation: Day-100 Outcomes Across Engraftment, Chimerism, GVHD, and V
111 Praveen Kumar Nil Ratan Sircar (NRS) Medical College & Hospital, Kolkata Herpes Zoster Ophthalmicus with Predominant Neuralgic Presentation in a Haploidentical Transplant Recipient: A Late Post-Transplant Infectious Complication and Implications for Immunization Strategies
112 Kaustabh Adhikari PGIMER, Chandigarh Molecular Analysis of Minor Histocompatibility Antigens in Indian Population for Plausible Relevance in Hematopoietic Stem Cell Transplantation- An Interim Report
113 Vignesh Subramani Homi Bhabha Cancer Hospital & Research Centre, Visakhapatnam Demographics and Toxicities of Autologous Hematopoietic stem cell transplant( ASCT) in a newly commissioned transplant centre at a tertiary Cancer Care Hospital
114 Somanapally Venu Malabar Cancer Centre, Kannur Outcomes of haploidentical allogeneic hematopoietic stem cell transplantation using post-transplant cyclophosphamide at a tertiary care centre in India: A retrospective analysis
116 Saswata Saha Tata Medical Center, Kolkata Transplant patterns and outcomes in Hodgkins Lymphoma – Single center experience over last 14 years
117 Anagha Kulkarni MCGM, Mumbai Outcomes of Hematopoietic stem cell transplant in pediatric AML: Experience of a public sector hospital in Mumbai
118 Himanshu Christian Medical College, Ludhiana Flexible and Bayesian survival modelling for post-transplant survival prediction in thalassemia major: a single-centre retrospective cohort study.
119 Sunisha Arora Fortis Memorial Research Institute, Gurgaon Tocilizumab for Cytokine Release Syndrome Management after Alternate Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide
122 Amrit Kaur Max Super Speciality Hospital (Dwarka), New Delhi Haploidentical HSCT with PTCy in a 6 month old with LAD I: A Novel ITGB2 mutation
124 Kiran N Malabar Cancer Centre, Kannur Profile and outcomes of hematopoietic stem cell transplantation for inborn errors of immunity: a single-center experience
125 Satyendra Katewa Max Hospital Patparganj, Delhi Vedolizumab-Based Gut Management in Children Undergoing HSCT with Pre and Post-transplant Intestinal Inflammation: A Case Series
126 Sheetal Sharma Choithram Hospital & Research Centre, Indore Effectiveness of aggressive nutritional protocol in pediatric bone marrow transplant patients
127 Satyendra Katewa Max Hospital Patparganj Delhi, Delhi Prophylactic Blinatumomab After HSCT in High-Risk B-ALL to decrease the relapse rates: A Single-Centre Experience
129 Gokulakrishnan T Apollo Cancer Speciality Hospital, Chennai Myeloablative Total Marrow and Lymphoid Irradiation (MA TMLI) Based Conditioning for Haploidentical Transplantation in Adult Leukemia.
130 Maharshi Trivedi The Gujarat Cancer and Research Institute, Ahmedabad Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for Transfusion-Dependent Thalassemia: A Single-Center Experience
131 Rashmi Ranjan Pradhan ACTREC, Mumbai Hemorraghic Cystitis Post Allogeneic Hematopoietic Stem Cell Transplantation- Risk factors and Treatment Outcomes
134 Nikitha Lakkaula Rainbow Childrens Hospital , Hyderabad Hematopoeitic Stem Cell Transplantation in Rare Metabolic disorders – A Case Series from Tertiary Care Centre.
135 Minakshi Balwani Apollo Cancer Speciality Centre, Chennai Plerixafor augmented peripheral blood stem cell mobilization in donors for Pediatric HSCT
137 Sachin Punatar ACTREC, Tata Memorial Centre, Navi Mumbai Acute complications, TRM and long-term outcomes of CML chronic phase transplants with 1 TKI failure vs >1 TKI failure
138 Lancy Flora Gleneagles Hospitals, Chennai Oral multi-drug regimen for the management of Post-BMT Haemorrhagic cystitis in Children
139 Nithya Seshadri Apollo Cancer Specialty Centre , Chennai The emerging risk of adenoviral infection in children undergoing alternate donor HSCT: a single-center study from Southern India
140 Sunisha Arora Fortis Memorial Research Institute, Gurgaon Matched donor hematopoietic stem cell transplantation in children with transfusion dependent thalassemia using treosulfan-thiotepa-fludarabine based conditioning
141 Mahafrin Homiar Goiporia Bai Jerbai Wadia hospital for Children, Mumbai HLA-Mismatched (9/10) Donor HSCT as a Feasible Alternative for Pediatric Patients Lacking a Fully Matched Donor
142 Minakshi Balwani Apollo Cancer Speciality Centre, Chennai Memory Matters: CD45RO⁺ T-Cell Add-Back Enhances Outcomes in TCRαβ/CD19-Depleted Haploidentical HSCT in Children
143 Suganya Mani Madras Medical College, Chennai Outcomes of Tocilizumab in the management of Cytokine Release Syndrome following Haploidentical Hematopoietic Stem Cell Transplantation,A Retrospectic study
144 Vinoth Kumar Murugesan Madras Medical College, Chennai Breakthrough Herpes Zoster despite Acyclovir Prophylaxis in Post Hematopoeitic Stem Cell Transplant Recipients: A Retrospective Study
146 Santoshkumar S Asangi MCGM, Mumbai Letermovir as Primary Prophylaxis in Pediatric Allogeneic HSCT: Single-Center Experience
147 Gokulakrishnan T Apollo Cancer Speciality Hospital, Chennai Chemotherapy Free Conditioning with Total Marrow and Lymphoid Irradiation in Adult Leukemics. A Novel Myeloablative ( MA) Strategy.
148 Arpita Gupta LTMMC and GH , Mumbai TpoR Agonists for Post-Transplant Thrombocytopenia in Paediatric HSCT: A Single-Centre Case Series
150 Foram Joshi Kidwai Memorial Institute of Oncology , Bangalore Harnessing Quality Improvement In Bone marrow Transplantation “RESCUE Score” : First-in-Centre AI Framework for Quality Evaluation and Outcome Correlation in Indian Resource-Limited Bone Marrow Transplantation
151 Deep Gala ACTREC, Tata Memorial Hospital, Navi Mumbai Haploidentical stem cell transplant with post-transplant Cyclophosphamide and CD45 RO addback- A single centre experience
152 Samyukta Shyam M S Ramaiah, Bengaluru Novel prophylaxis to prevent TA-TMA in Haplo-identical Hematopoietic Stem Cell Transplantation: A Single-Center Experience
153 Bishal Sharma Tata Memorial Centre, Mumbai Morbidity Burden, Social Rehabilitation, Fertility  and Quality of Life in Long-Term Survivors of Haematopoietic Cell Transplantation: A Single-Centre Experience from India
154 Parichay Singh Homi Bhabha Cancer Hospital, Varanasi Taking the breaks off the CART19 using checkpoint inhibitor
155 Shobha Badiger Mazumdar Shaw Medical Centre, Bengaluru Addition of Low-Dose Total Body Irradiation to FTTA Conditioning Reduces Mixed Chimerism in Paediatric Thalassemia HSCT: A Consecutive Cohort Study
156 Anupam Chakrapani Apollo Multispeciality Hospital, Kolkata  BEAM based conditioning regimen in Lymphoma Auto transplant: 10-year outcome data from Eastern India.
157 Jatan Jagruk MCGM CTC, Mumbai Dynamics of Immune Reconstitution and Viral Reactivation Patterns in Pediatric T-cell Replete Haploidentical Hematopoietic Stem Cell Transplantation
158 Pratibha Singh Nil Ratan Sircar Medical College & Hospital, Kolkata Determinants of Peripheral Blood Stem Cell (PBSC) Mobilisation and Impact on Outcomes in Autologous Hematopoietic Stem Cell Transplantation: A Single-Centre Clinical Analysis
159 Adalene Rana Madras Medical College, Chennai Beyond Engraftment: Bridging the Gap with a Community-Integrated Housing Model for Post-Transplant Recovery
160 Sania Taneja Jaslok Hospital and Research Centre, Navi Mumbai EBV-associated plasmacytic post-transplant lymphoproliferative disorder (PTLD) with concurrent viral reactivation and GVHD following allogeneic HSCT: a diagnostic and therapeutic challenge.
161 Sudipto Bhattacharya Post Graduate Institute of Child Health, Noida Optimizing Outcomes in Pediatric Aplastic Anemia: A Single-Center Experience with Matched and Haploidentical Hematopoietic Stem Cell Transplantation
162 Asha Alexander Madras Medical College, Chennai The critical role of enrichment programmes for caregivers of Bone Marrow Transplant patients: A literature review on caregivers well-being and its impact on patient recovery
163 Sunil Chopade Jaslok Hospital & Research Centre, Mumbai Outcomes of Autologous  Hematopoietic Stem cell transplant for lymphomas  : an experience from single tertiary care Centre in India
165 Muthulakshmi Ramraj Madras Medical College, Chennai Pattern and Clinical Impact of Total Parenteral Nutrition Use in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Study
166 Anupam Chakrapani Apollo Multispeciality Hospital, Kolkata Rocking result in case of severe Occular GVHD with rock 2 inhibitor
168 Binita Poudel CTC, PHO and BMGT Center, Mumbai Clinical Profile and Outcomes of Acute Graft-versus-Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Single-Centre Study
169 Vijayshree Muthukumar Apollo Hospitals, Chennai Open-Label, Prospective, Randomized, Comparative Clinical Study Evaluating the Effects of AFO-202 Strain of Aureobasidium pullulans-Produced β-1,3-1,6 Glucans (Nichi BRITE) in HSCT
170 Sudeep Gaddam Sindhu Hospitals, Hyderabad Treosulfan-Based FTTA Conditioning for High-Risk Transfusion-Dependent Thalassemia: A Single-Center Experience from India
171 Praise Susan Abraham Aster MIMS, Calicut Anti-CD19 CAR-T Cell Therapy in Refractory B-Cell Lymphoma: Experience from a Tertiary Care Centre in Southern India
172 Athira Valsarajan Aster MIMS calicut, calicut Clinical Profile and Outcomes of CMV Reactivation in Post HSCT in a Tertiary Care Center
173 Niveditha.S. Reddy Mazumdar Shaw Medical Centre, Bangalore Comparison of Haplo-identical Stem Cell Transplant using TCR alpha/beta depletion with Post Transplant Cyclophosphamide in Pediatric Leukemias
174 Ranjit Sahoo AIIMS, New Delhi Concordance with EBMT recommendations for GVHD management: a national survey of Indian BMT physicians
175 Pallati Mounika AIIMS, New Delhi High dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumors: a single-center experience
178 Desai Rachit Jasminbhai ACTREC, Navi Mumbai Long term responders to autologous stem cell transplant in multiple myeloma -incidence, characteristics and predictive factors, a retrospective single centre study
179 Megadeepan Senthilkumar Kidwai Memorial Institute of Oncology, Bengaluru Pre-transplant undernutrition predicts increased resource utilization and delayed platelet recovery in paediatric autologous HSCT
180 Goutomi Chatterjee Basavatarakam Indo-American Cancer Hospital, Hyderabad Autologous haematopoietic stem cell transplantation in high-risk neuroblastoma: retrospective analysis from a tertiary care centre in Deccan India
183 Megadeepan Senthilkumar Kidwai Memorial Institute of Oncology, Bengaluru Renal Reserve Guided Conditioning in High Risk Relapsed Wilms Tumour: A Case Supporting Thiotepa–Melphalan as a Renal Sparing Alternative
184 Rashmi Max Super Speciality Hospital Saket, Delhi Clinical outcomes of Autologous BMT in Multiple Myeloma patients following Daratumumab-Based Quadruple Therapy in real world settings
187 Roshan Christopher Ross Health Care Global (HCG), Bangalore Comparative Outcomes of Standard Care Versus Ruxolitinib+ Standard Of Care for GVHD Management After Allogeneic Stem Cell Transplant: A Comprehensive Analysis
188 Ruthvik T V St. John’s Hospital, Bangalore Management of BK viral infection-hemorrhagic cystitis in post allogeneic stem cell transplant
189 Sudipto Bhattacharya Post Graduate Institute of Child Health,Noida, Noida Profile of paediatric patients with Graft versus Host Disease: A Single-Center Experience with Matched and Haploidentical Hematopoietic Stem Cell Transplantation
190 Sabitha Paramasivam All India Institute Of Medical Sciences, New Delhi Post-transplant cyclophosphamide (PTCy) plus Anti-thymocyte globulin (ATG) for GVHD prophylaxis in paediatric haploidentical hematopoietic stem cell transplantation (HSCT); a retrospective analysis
191 Himani Gupta Rajiv Gandhi Cancer Institute and Research Centre , New Delhi Donor Lymphocyte Infusion After Haploidentical HSCT in Hematological Malignancies: Real-World Outcomes from a Single Center
192 Brundavanam Venkata Krishna Sai Rainbow Hospital Hyderabad , Guntur High Dose Chemotherapy With Autologous Stem Cell Rescue in Pediatric Solid tumours
193 Punkesh Patel JIPMER, Pondicherry Haploidentical Hematopoietic Stem Cell Transplant with Alpha-Beta T-Cell Depletion in an 8-Year-Old Child with Li-Fraumeni Syndrome
194 Vishvdeep Khushoo AIIMS, Nagpur Parvovirus B19 and cytomegalovirus co‑infection following autologous stem cell transplantation leading to prolonged cytopenias in a paediatric B‑cell non‑Hodgkin lymphoma patient: a case report
195 Asmita Gawde Bai Jerbai Wadia Hospital for Children, Mumbai Timing matters: Predictors of outcome in severe aplastic anemia
196 Rachit Medanta Medicity, Gurugram Immune Reconstitution Following Second Allogeneic HSCT in Pediatric Patients: A Single-Centre Experience
201 Advait Pramod Dubey ACTREC, Tata Memorial Centre, Navi Mumbai Discovery and Development of Drugs against Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
204 Suganya Jaganathan Madras Medical College, Chennai Regulatory Gaps in India’s Advanced Therapy Medicinal Product Pathway: Bridging Safe and Effective Clinical Translation
207 Chaitanya G.B Sindhu Hospitals, Hyderabad Bloodstream Infections in the Early Post-Bone Marrow Transplant Period: A Retrospective Observational Study